Repare Therapeutics
Clinical trials sponsored by Repare Therapeutics, explained in plain language.
-
Early cancer drug combo trial halted by sponsor
Disease control TerminatedThis study aimed to test the safety and find the right dose of two different oral drug combinations for adults with advanced solid tumors that have specific genetic markers and have stopped responding to standard treatments. The trial was terminated early by the sponsor, so the m…
Phase: PHASE1, PHASE2 • Sponsor: Repare Therapeutics • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Early cancer drug trial halted after testing on 26 patients
Disease control TerminatedThis early-stage trial tested the safety of an experimental drug called RP-3467, both alone and combined with an existing cancer drug (olaparib), in adults with advanced solid tumors. The study aimed to find the highest safe dose and understand how the body processes the drug. It…
Phase: PHASE1 • Sponsor: Repare Therapeutics • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Early cancer pill trial halted after testing on 29 patients
Disease control TerminatedThis was an early safety study for a new oral cancer drug called RP-1664. It tested the drug in 29 people with advanced solid tumors that had stopped responding to other treatments. The main goals were to find a safe dose and see how the drug behaved in the body, but the trial wa…
Phase: PHASE1 • Sponsor: Repare Therapeutics • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC